Home » Topics » New compound, BioWorld Science

New compound, BioWorld Science
RSS

Potent, non-redox 5-LO inhibitor identified by Merck Frosst

Oct. 25, 1996

Bristol-Myers Squibb describes potent and selective beta3-adrenoceptor agonist

Oct. 25, 1996

LTA4 hydrolase inhibitor effective in ulcerative colitis

Oct. 18, 1996

Servier selects TxA2 antagonist for further study

Oct. 18, 1996

Antithrombotic prostaglandin analogue revealed by Asahi Glass

Oct. 18, 1996

New FLAP inhibitor presented by Abbott

Oct. 18, 1996

CGP-57698: Follow-up compound to iralukast reported by Ciba-Geigy

Oct. 18, 1996

Menarini studies LTD4 antagonists for asthma Rx

Oct. 18, 1996

Tyrosine kinase inhibitor developed by Cephalon and TAP enters clinical trials

Oct. 18, 1996

New cPLA2 inhibitor from Merckle

Oct. 18, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...